LIVE
Video
Dr Jasmine Bagga, Application Scientist, APAC Biotech, Gurugram
TRENDING NEWS
- POLICY & REGULATORY
-
Prices of oxygen concentrators come down upto 54%
114-bedded covid care facility opens in Bhilai Steel Plant
Health Ministry orders 44 Cr doses of COVID-19 vaccines till Dec 21
- FINANCE
-
KIMS Hospitals IPO to open on June 16, 2021
Pee Safe raises Rs 25-Cr Pre-Series B funding
Tata Digital to acquire majority stake in 1MG
- COMPANY
-
KIMS Hospitals IPO to open on June 16, 2021
Hyd-based Biophore applies for DCGI approval of Aviptadil
Alkem Labs launches epilepsy drug at affordable price
- WORLD
-
Ocugen expands COVAXIN commercialisation rights to include Canada
Organon & Co launches women’s health company in India
RDIF, UNICEF ink Sputnik V vaccine supply agreement
-
Science | 11 June 2021 | News
CSIR-CDRI to develop safer drug for heart attack and stroke
CSIR – Central Drug Research Institute (CDRI), Lucknow is committed to support Pharma Cluster in Ut...Read more
-
Interviews | 10 June 2021 | Views
'Genes2me has delivered more than 40 M COVID-19 testing kits till date'
How has the molecular diagnostics market evolved in the last decade? Conventionally, the power of mol...Read more
-
Analysis | 12 June 2021 | News
Can India re-visit UK’s stand on gap between two COVID-19 jabs?
The UK government has reduced the gap between two doses of COVID-19 vaccines from 12 weeks to 8 weeks for the ...Read more
-
Start-ups | 10 June 2021 | News
Parisodhana Technologies brings alternative to N95 respirator
N95 face masks have been considered more effective in reducing the transmission of COVID-19 virus from an infe...Read more
-
Supplier | 08 June 2021 | News
Thermo Fisher unveils assay to improve SARS-CoV-2 surveillance
Thermo Fisher Scientific has introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improv...Read more
-
Health IT | 08 June 2021 | News
CitiusTech appoints Bhaskar Sambasivan as President
Healthcare technology services provider CitiusTech has appointed Bhaskar Sambasivan as President. Sambasivan w...Read more
-
Academics | 12 June 2021 | News
IIT-B sets up first-of-its-kind centre for digital health education
IIT Bombay has set up the 'Koita Centre for Digital Health' (KCDH) with a generous contribution received from ...Read more
-
Blogs | 24 May 2021 | Views
Improving & enhancing the medical resources
It is laudable that our Honourable Prime Minister is putting all possible efforts to enhance the medical resou...Read more
Videos
Inside Magazine
MALARIA DENGUE TB PLAY SECOND FIDDLE TO COVID-19
Although India has worked relentlessly towards developing innovative testing solutions for COVID-19 throughout last year, the timely detection of a number of other infectious diseases has been sidelined. In India, the range and burden of infectious diseases such as tuberculosis, malaria, filariasis, leprosy, HIV infection, typhoid, hepatitis etc., are enormous. In fact, inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of chikungunya virus disease and typhus fever. If India can develop more than 20 different diagnostic tests or devices in a single year to fight COVID-19, many more such innovations can be brought to effectively detect other infections looming in our country.
For Feedback, please email us at : communications@mmactiv.com
-- BioSpectrum Infomercial
